Some major American healthcare providers are padding their bottom lines by exploiting a federal program meant to help low-income patients. This behavior is netting them billions in ill-gotten gains. And it could be preventing many vulnerable Americans from accessing the low-cost drugs they need to treat and prevent illness. Continue reading